Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects
Javier Traba, … , Richard M. Siegel, Michael N. Sack
Javier Traba, … , Richard M. Siegel, Michael N. Sack
Published November 3, 2015
Citation Information: J Clin Invest. 2015;125(12):4592-4600. https://doi.org/10.1172/JCI83260.
View: Text | PDF
Clinical Research and Public Health Metabolism Article has an altmetric score of 83

Fasting and refeeding differentially regulate NLRP3 inflammasome activation in human subjects

  • Text
  • PDF
Abstract

BACKGROUND. Activation of the NLRP3 inflammasome is associated with metabolic dysfunction, and intermittent fasting has been shown to improve clinical presentation of NLRP3 inflammasome–linked diseases. As mitochondrial perturbations, which function as a damage-associated molecular pattern, exacerbate NLRP3 inflammasome activation, we investigated whether fasting blunts inflammasome activation via sirtuin-mediated augmentation of mitochondrial integrity.

METHODS. We performed a clinical study of 19 healthy volunteers. Each subject underwent a 24-hour fast and then was fed a fixed-calorie meal. Blood was drawn during the fasted and fed states and analyzed for NRLP3 inflammasome activation. We enrolled an additional group of 8 healthy volunteers to assess the effects of the sirtuin activator, nicotinamide riboside, on NLRP3 inflammasome activation.

RESULTS. In the fasting/refeeding study, individuals showed less NLRP3 inflammasome activation in the fasted state compared with that in refed conditions. In a human macrophage line, depletion of the mitochondrial-enriched sirtuin deacetylase SIRT3 increased NLRP3 inflammasome activation in association with excessive mitochondrial ROS production. Furthermore, genetic and pharmacologic SIRT3 activation blunted NLRP3 activity in parallel with enhanced mitochondrial function in cultured cells and in leukocytes extracted from healthy volunteers and from refed individuals but not in those collected during fasting.

CONCLUSIONS. Together, our data indicate that nutrient levels regulate the NLRP3 inflammasome, in part through SIRT3-mediated mitochondrial homeostatic control. Moreover, these results suggest that deacetylase-dependent inflammasome attenuation may be amenable to targeting in human disease.

TRIAL REGISTRATION. ClinicalTrials.gov NCT02122575 and NCT00442195.

FUNDING. Division of Intramural Research, NHLBI of the NIH.

Authors

Javier Traba, Miriam Kwarteng-Siaw, Tracy C. Okoli, Jessica Li, Rebecca D. Huffstutler, Amanda Bray, Myron A. Waclawiw, Kim Han, Martin Pelletier, Anthony A. Sauve, Richard M. Siegel, Michael N. Sack

×

Total citations by year

Year: 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2011 2009 Total
Citations: 9 15 9 17 13 9 10 8 8 7 1 1 107
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article in year 2019 (10)

Title and authors Publication Year
Impaired ketogenesis and increased acetyl-CoA oxidation promote hyperglycemia in human fatty liver
Justin A. Fletcher, Stanislaw Deja, Santhosh Satapati, Xiaorong Fu, Shawn C. Burgess, Jeffrey D. Browning
JCI Insight 2019
Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease
MY Donath, DT Meier, M Böni-Schnetzler
Endocrine reviews 2019
Autophagy and cardiac aging
S Miyamoto
Cell Death and Differentiation 2019
Associations of variants In the hexokinase 1 and interleukin 18 receptor regions with oxyhemoglobin saturation during sleep
BE Cade, H Chen, AM Stilp, T Louie, S Ancoli-Israel, R Arens, R Barfield, JE Below, J Cai, MP Conomos, DS Evans, AC Frazier-Wood, SA Gharib, KJ Gleason, DJ Gottlieb, DR Hillman, WC Johnson, DJ Lederer, J Lee, JS Loredo, H Mei, S Mukherjee, SR Patel, WS Post, SM Purcell, AR Ramos, KJ Reid, K Rice, NA Shah, T Sofer, KD Taylor, TA Thornton, H Wang, K Yaffe, PC Zee, CL Hanis, LJ Palmer, JI Rotter, KL Stone, GJ Tranah, JG Wilson, SR Sunyaev, CC Laurie, X Zhu, R Saxena, X Lin, S Redline, CG Montgomery
PLoS genetics 2019
Annexin A1 Bioactive Peptide Promotes Resolution of Neuroinflammation in a Rat Model of Exsanguinating Cardiac Arrest Treated by Emergency Preservation and Resuscitation
Q Ma, Z Zhang, JK Shim, TN Venkatraman, CD Lascola, QJ Quinones, JP Mathew, N Terrando, MV Podgoreanu
Frontiers in neuroscience 2019

Novel role of NLRP3-inflammasome in regulation of lipogenesis in fasting-induced hepatic steatosis


B Liu, X Mao, D Huang, F Li, N Dong
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2019
Recurrent circadian fasting (RCF) improves blood pressure, biomarkers of cardiometabolic risk and regulates inflammation in men
I Alam, R Gul, J Chong, CT Tan, HX Chin, G Wong, R Doggui, A Larbi
Journal of Translational Medicine 2019
Diverse therapeutic efficacies and more diverse mechanisms of nicotinamide
SB Song, JS Park, GJ Chung, IH Lee, ES Hwang
Metabolomics 2019
Diet in Parkinson's Disease: Critical Role for the Microbiome
A Jackson, CB Forsyth, M Shaikh, RM Voigt, PA Engen, V Ramirez, A Keshavarzian
Frontiers in neurology 2019
Modulation of senoinflammation by calorie restriction based on biochemical and Omics big data analysis
Bang E, Lee B, Noh SG, Kim DH, Jung HJ, Ha S, Yu BP, Chung HY
BMB Reports 2019

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 6 news outlets
Blogged by 4
Posted by 16 X users
On 3 Facebook pages
Mentioned in 2 Google+ posts
Reddited by 1
Highlighted by 1 platforms
On 7 videos
162 readers on Mendeley
1 readers on CiteULike
See more details